NovoCure Ltd.
(NASDAQ : NVCR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 0.95%582.821.0%$844.15m
DHRDanaher Corp. 0.26%301.200.7%$674.24m
ABTAbbott Laboratories -0.09%117.460.8%$620.40m
MDTMedtronic Plc 2.32%127.700.6%$526.13m
ALGNAlign Technology, Inc. -1.36%589.616.3%$337.47m
BDXBecton, Dickinson & Co. -0.61%241.201.0%$335.40m
ISRGIntuitive Surgical, Inc. 0.17%331.500.8%$317.01m
SYKStryker Corp. 0.96%266.381.3%$284.16m
DXCMDexCom, Inc. -1.81%544.477.8%$282.68m
IDXXIDEXX Laboratories, Inc. 0.86%635.153.8%$276.25m
EWEdwards Lifesciences Corp. 0.59%112.230.4%$260.36m
BSXBoston Scientific Corp. 0.44%43.441.0%$256.50m
AAgilent Technologies, Inc. 0.54%153.421.6%$222.45m
BAXBaxter International, Inc. -0.26%79.681.8%$200.18m
ZBHZimmer Biomet Holdings, Inc. 0.81%146.811.7%$174.98m

Company Profile

NovoCure Ltd. develops treatment for tumors. Its platform is called the Tumor Treating Field which used electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.